To determine whether the antitumor efficacy of JMJD6 knockdown was macrophage-dependent, mice were administered with clodronate liposomes (CLO Lipo) to deplete macrophages during the course of tumor growth. This evidence concerns the gene JMJD6 and neoplasm.